Newron Pharmaceuticals (NWPHF) Short Interest Ratio & Short Volume

Short interest is the volume of Newron Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 44,600 shares of NWPHF short. Learn More on Newron Pharmaceuticals' current short interest.

Newron Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 44,600 shares, an increase of 50.7% from the previous total of 29,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Newron Pharmaceuticals: FibroGen, Inc. (5.65%), Elite Pharmaceuticals, Inc. (0.15%), Repare Therapeutics Inc. (2.39%), Spyre Therapeutics, Inc. (9.36%), Syros Pharmaceuticals, Inc. (9.89%), I-Mab (1.45%), Vistagen Therapeutics, Inc. (5.27%), Relmada Therapeutics, Inc. (5.60%), CervoMed Inc. (0.60%), Citius Pharmaceuticals, Inc. (7.81%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling NWPHF is an investing strategy that aims to generate trading profit from Newron Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Newron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NWPHF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWPHF, twice per month. The most recent reporting period available is March, 31 2024.